Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2024 May 22;19(5):e0287243. doi: 10.1371/journal.pone.0287243

A study protocol for predictors of post-discharge mortality among children aged 5–14 years admitted to tertiary hospitals in Tanzania: A prospective observational cohort study

Elton Roman Meleki 1,*, Stella Mongella 2,*, Francis Fredrick Furia 1,*
Editor: Deogratias Munube3
PMCID: PMC11111011  PMID: 38776310

Abstract

Introduction

Globally, millions of children and adolescents die every year from treatable and preventable causes. Sub-Saharan Africa accounted for 55% of deaths of children aged 5–14 years in 2017. Despite this high burden, minimal effort has been directed toward reducing mortality among older children and adolescents in comparison to under-fives. Mortality rates of children post-discharge vary between 1–18% in limited-resource countries and are reported to exceed in-hospital mortality. In Tanzania, there is limited data regarding post-discharge mortality and its predictors among children aged 5–14 years.

Objectives

This study aims to determine the post-discharge mortality rate and its predictors among children aged 5–14 years admitted to pediatric wards at MNH, MOI, and JKCI.

Methods and analysis

This will be a prospective observational cohort study that will be conducted among children aged 5–14 years admitted to pediatric wards at Muhimbili National Hospital, Jakaya Kikwete Cardiac Institue, and Muhimbili Orthopedic Institue in Dar-Es-Salaam, Tanzania. Data will be collected using a structured questionnaire and will include socio-demographic characteristics, clinical factors, and patients’ outcomes. Post-discharge follow-up will be done at months 1, 2, and 3 after discharge via phone call. Data will be analyzed using SPSS version 23. The association of demographic, social economic, and clinical factors with the outcome of all causes, 3 months post-discharge mortality will be determined by Cox regression, and survival rates will be displayed through Kaplan-Meier curves.

Discussion

This study will determine post-discharge mortality among children aged 5–14 years and its predictors in Tanzania. This information is expected to provide baseline data that will be useful for raising awareness of clinicians on how to prioritize and plan a proper follow-up of children following hospital discharge. These data may also be used to guide policy development to address and reduce the high burden of older children and adolescent mortality and may be used for future studies including those aiming to develop prediction models for post-discharge mortality among older children and adolescents.

Background

Over the last thirty years, there has been a significant decline in mortality among children <5 years with nearly all global regions implementing Sustainable Development Goals (SDG) reducing mortality among children <5 years by almost half. The same has also occurred for older adolescents and youths aged 15–24 years whose trend of mortality has declined significantly similar to that of under-five [13]. On the other hand, mortality reduction in children between 5–14 years has remained stagnant for the same duration of time and no significant interventions have been put forward [1, 4, 5].

Approximately 1 million children aged 5–14 years died in 2017 with nearly all these deaths occurring in lower- and middle-income countries with more than half involving children in Sub-Saharan Africa [2, 6]. Causes of mortality among older children and young adolescents differ across the globe, most deaths are attributed to injuries, malignancy, congenital defects, and infectious causes including enteric infections, neglected tropical diseases, meningitis, and malaria [1, 5, 79]. Infectious causes are predominant in lower- and middle-income countries, particularly in Sub-Saharan Africa [5, 1013].

Improvement of health services has supported early detection and treatment of most clinical conditions during hospitalization with improved survival and discharge [12, 14]. There is limited information on the mortality after discharge, especially for children aged 5–14 years. Several studies have documented post-discharge mortality among children in Sub-Saharan Africa, however, there is a lack of disaggregated data for children aged 5–14 years. The limited available data have provided useful information for children below 5 years including clinical profile, socio-demographic features and major predicting factors for mortality [12, 1518].

This study will determine post-discharge mortality and its predicting factors among children aged 5–14 years in Tanzania. This study will provide important information to inform practicing clinicians, policymakers, and other interested stakeholders involved in the provision of care for children in Tanzania and the Sub-Saharan Africa region. This information will also provide baseline data for future studies including those aiming at developing a prediction model for post-discharge mortality for older children and adolescents in the Sub-Saharan Africa region.

Research questions

  1. What is the mortality for children aged 5–14 years within 3 months following discharge from pediatric wards at MNH, JKCI, and MOI?

  2. What are the predictors of post-discharge mortality among children aged 5–14 years admitted to pediatric wards at MNH, JKCI, and MOI?

Methodology/Design

Study design and aim

A prospective observational cohort study will be conducted in pediatric departments of Muhimbili National Hospital (MNH), Jakaya Kikwete Cardiac Institute (JKCI), and Muhimbili Orthopedics Institute (MOI) to analyze mortality at 3 months post-discharge and its predictors among children aged 5–14 years.

Study setting

This study will be conducted at MNH, JKCI, and MOI which are public National institutes of health housed within the same grounds in Dar-Es-Salaam. They all serve as teaching hospitals for Muhimbili University of Health and Allied Sciences (MUHAS). JKCI and MOI are super-specialized hospitals providing cardiac, neurosurgical, and trauma tertiary care services respectively. The pediatric units in all three hospitals admit children from 0 days to 14 years. The three institutes were chosen because they receive patients from all over Tanzania and the results can be generalized. They also represent different specialties to reflect children of all diagnoses.

MNH has a bed capacity of more than 1500 and attends to about 2,000 outpatients per day. The pediatric unit at MNH has 6 units namely; general pediatrics, acute care unit, infectious/diarrhea unit, malnutrition unit, hematology-oncology unit, and neonatal unit. The pediatric building also houses other specialized units such as surgery, ophthalmology, burn, dental, ENT, and urology for children.

JKCI has a 103-bed capacity and 198 staff attending on average 700 outpatients and 100 in-patients per week while MOI has a bed capacity of 362, with over 100 medical specialists attending about 1000 outpatients per week. The building of MOI houses two specialized pediatric units which are the trauma, the orthopedic unit, and the neurosurgical unit.

Study population and sample size

This study will enroll all children aged 5–14 years before discharge from pediatric wards at the three hospitals after they provide assent and their caregivers’ consent to participation. The sample size was calculated from open Epi using the Fleiss method for rates and proportions [19]. The candidate variables for clinical prediction were considered in sample size calculation utilizing findings from a previous study conducted in Northern Tanzania [15].

The variables included were low hemoglobin level, proteinuria, hematuria, having a diagnosis of cancer, heart disease, sickle cell disease, neurological disease, and clinical findings of higher respiratory rate, low oxygen saturation, low GCS, reduced urine output, and lower limb edema. All the variables were entered into the formula comparing outcomes among exposed and unexposed. The variable that gave the largest sample size was selected. The post-discharge mortality from those who presented with hematuria which was 40% gave the largest sample size, and hence it was selected.

A power of 80% was selected with a two-sided confidence level of 95%. The ratio of unexposed to exposed was 24.3. The percentage of those exposed with an outcome that in the selected study was the mortality among those who had hematuria on urinalysis was 40%. The percentage of unexposed with outcome was 16%. The odds ratio was 2.5. The sample size of exposed was 28 and of unexposed 669 making a total of 697. The sample size was adjusted for a 5% non-response rate and the final sample size was 734 participants. The participants will be recruited conveniently before their discharge.

Variables

The variables have been selected based on the literature. Table 1 below represents predicting variables. There is evidence that demographic characteristics are predictors of mortality. A recent systematic analysis of the global burden of diseases revealed age and sex variation in terms of mortality in children. The age between 10–14 years is considered early adolescence and children at this age are more prone to make poor decisions in highly emotionally charged situations compared to children aged 5–9 years [20].

Table 1. Candidate variables for predicting post-discharge mortality.

Demographics Social economic factors Admission type Clinical data
• Age of the child
• Sex of the child
• Caregiver’s level of education
• Caregiver’s age
• Caregiver’s marital status
• Caregiver’s employment status
• Type of toilet used in the home
• Type of material the floor, wall and roof of the house is made of.
• self-referral
• Admission from clinic
• Referral from another hospital
• Admitting complains
• Vitals at admission
• Duration of hospital stay
• Duration of illness
• Prior treatment
• Clinical signs
• Laboratory parameters
• Abnormal imaging
• Type of discharge (absconded, against medical advice, or medical)

Similarly, educational status of the caregivers has also been shown to predict mortality, and this was reported from a study done in the Philippines where children born to less educated mothers had higher risks of post-discharge mortality. The same was reported in the study that was done in Guinea [18].

There is also evidence of socioeconomic status and clinical characteristics as predictors of mortality from various studies. A few available studies have reported poor housing quality, length of hospital stay, discharge against medical advice, presence of chronic illnesses, and severe anemia amongst others as predictors of mortality [12, 16, 17, 21].

Hence, there is clear evidence that socioeconomic, demographics, and clinical characteristics can predict mortality. However, a majority of this literature does not have disaggregated data for children aged 5–14 years. The variables selected in Table 1 below are going to be evaluated to determine the predictors of mortality in this age group of children.

The outcome variables presented on Table 2 below have also been selected based on literature. The global programs are all aimed at reducing childhood and youth mortality. There is compelling evidence that post-discharge mortality exceeds in-hospital mortality in Sub-Saharan Africa however there is no disaggregated data for children aged 5–14 years [22]. The available data provides useful information for children below the age of five. The primary outcome as shown on Table 2 below is post-discharge mortality, but we also assess other outcomes such as readmission, unplanned hospital visits and use of herbal medications.

Table 2. Outcome variables.

Primary outcome Secondary outcomes
post-discharge mortality at 3 months • Readmission
• Unplanned hospital visits
• Use of herbal medication

Data collection

Data will be collected by three research assistants and the study’s primary investigator. The three assistants will be medical officers who are not directly involved in the care of the patient. The research assistants will be familiarized with the questionnaire by going through the questions together with the study’s primary investigator. A pilot will be conducted to evaluate the questionnaire and competencies of the research assistants. Study participants will be identified prior the discharge and those eligible will be enrolled.

A structured questionnaire will be used for data collection, which will include the demographics of both the caregiver and the participant, socio-economic factors of the caregiver, participants’ in-patient clinical information at admission and during the hospital stay, and outpatient outcomes. The questionnaire will also include the caregiver’s contacts. The patient’s clinical information in the questionnaire will be extracted by the research assistants from the patient’s file, while demographics, socioeconomic status and post-discharge follow-up will require interviewing the participant. The interviews will be done by the research assistants and the information will be recorded in the questionnaire.

The in-patient clinical data will include presenting signs and symptoms, and laboratory and imaging results which all shall be recorded in the questionnaire from the patient’s progress notes, laboratory, and radiology electronic systems respectively. The outpatient follow-up will be done at months 1, 2, and 3 after discharge from the hospital.

Follow-up will be through a phone call through which a questionnaire will be administered through the phone. The research assistants will be calling the study participants at months 1, 2, and 3 after discharge. The follow-up questionnaire will include the status of the participant if alive or deceased, the general condition of the participant, readmission, and unplanned hospital/outpatient visits. For the deceased individuals, a modified verbal autopsy will be conducted over the phone to establish the possible cause of death by the study’s primary investigator.

This modified verbal autopsy will consist of questions that aim at establishing the possible cause of death of the deceased. This will be administered over the phone to the caregiver/parent who was living with the child at the time of death.

Data collection tools

Data will be collected using structured questionnaires, which will be administered by the research assistants. The questionnaire will be administered through interviews and some other information will be recorded from the patient’s progress notes, laboratory and radiological results. The questionnaires are designed based on the research objectives to capture the most complete and accurate information possible. The questionnaires have also been designed to make it easy for the respondent to provide the necessary information and for the interviewer to record an accurate response. Data on the causes of death will be collected using a modified WHO verbal autopsy tool which is designed to capture the age of the participant at death, the place of death, general signs and symptoms of the illness that preceded death, and any treatment given before death [23]. It will also capture the possible causes that lead to the death of the deceased.

Data management

All data that is collected on paper-based forms will be stored by the primary investigator in a locked private cupboard that only research personnel will be able to access under the primary investigator’s permission. Research assistants together with the primary investigator will transfer the information from the paper forms to feed it to the SPSS software version 23. The files will later be merged for data cleaning and analysis.

Information will be confidential and no identifying information will be published or disseminated during the study period or upon completion of the study. Data will only be stored until publication, if the need arises for verification and paper forms will be burnt after the analysis is complete and the report has been written.

Data analysis

Data will be entered into SPSS version 23. Categorical variables will be described as proportions (percentage), and continuous variables as means with standard deviations. Univariable and multivariable Cox regression analysis will be used to determine factors associated with mortality. All factors that will be significantly associated with mortality in the univariable analysis will be included in the multivariable analysis and later adjusted for confounding variables.

The confounding variables will be identified from the conceptual diagram as those variables that are thought to be associated with the candidate predicting variables and all causes 3 months post-discharge mortality. The association of every potential confounder with the all causes, 3 months post-discharge mortality will be established using a likelihood ratio test.

The survival rate will be displayed using the Kaplan-Meier curve, and a log-rank test will be used to compare the mortality rates between different diagnosis categories, age groups (5–9 years versus 10–14 years), and gender. Hazard ratios and their 95% confidence intervals will be reported with a significance level of 5%. The missing data will be assessed for any potential biases and excluded in the analysis.

Ethical consideration

The study received ethical clearance from Muhimbili University of Health and Allied Sciences institutional review board with ethical clearance number 04-2023-1662.

Discussion

The study is intended to investigate the burden of post-discharge mortality among children aged 5–14 years in Tanzania. It also aims to determine the predicting factors for mortality 3 months after discharge from the hospital among children aged 5–14 years. The clinical characteristics, demographics, and socioeconomic factors are the candidate variables for clinical prediction. The candidate variables for clinical prediction will all be analyzed to associate their impact with the primary outcome.

The primary outcome will be measured as incidence. The study is also intended to study several other secondary outcomes including the readmission rate, and the number of unplanned hospital/outpatient visits after discharge from the hospital with the predicting factors. The results from this study will bring awareness to clinicians about post-discharge mortality and its predicting factors in children aged 5–14 years. The results are also expected to form baseline data for subsequent studies that will establish a prediction model for post-discharge mortality in children aged 5–14 years.

The cohort design allows determining the effect of multiple predicting variables on three months post-discharge mortality. The study will use a large sample size from three different tertiary facilities that receive patients from all over Tanzania, hence the results can be generalized. The enrollment of the participants will be convenient to avoid bias. Research assistants will be medical officers who are not involved directly with the care of the patients to minimize bias. The follow-up period is chosen to be three months since a majority of the deaths related to previous admissions are reported to occur early in the months following discharge. The longer the follow up the more likely to get unrelated causes where results interpretation will be difficult.

The results are expected to reveal the burden the post-discharge mortality and its predictors. The results will determine which clinical characteristics can be directly associated with high post-discharge mortality and which factors can be avoided to reduce the post-discharge mortality. The results will also determine at which time post-discharge most deaths occur and what are the major causes. Referring to the recent study from Northern Tanzania that included children aged 2–12 years, it is expected that chronic illnesses to be great predictors for post-discharge mortality. However, this study did not provide disaggregated data for children aged 5–14 years.

However, there are a few limitations to this study which are expected including the observational nature of the study makes it prone to miss some of the data due to lack of documentation. This could happen due to a lack of routine documentation of all patient clinical information most often due to a lack of necessary gadgets to measure some clinical parameters such as blood pressure.

It will also be difficult to establish the exact cause of death as a verbal autopsy will be conducted over the phone, and hence miss a chance to see some of the documents that could help in establishing the cause of death. Such documents include a death certificate or any hospital records and medication prescriptions that would help determine the possible cause of death. To overcome the limitation of over-the-phone verbal autopsy, for the deceased who died in the hospital the study is being conducted, and their documents will be collected from the hospital records.

Acknowledgments

I would like to acknowledge the Muhimbili University of Health and Allied Sciences for providing me with access to HINARI which has enabled me to access various literature from several databases including PubMed. The university provides the log in credentials to all students for HINARI.

List of abbreviations

GCS

Glasgow Coma Scale

HB

Hemoglobin

HINARI

Health Inter-Network Access to Research Initiatives

HIV

- Human Immunodeficiency Virus

JKCI

Jakaya Kikwete Cardiac Institute

MNH

Muhimbili National Hospital

MOI

Muhimbili Orthopedic Institute

PubMed

Public/Publisher Medline

SPSS

Statistical Package for Social Sciences

WHO

World Health Organization

Data Availability

No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.

Funding Statement

The authors received no specific funding for this work.

References

  • 1.IGME UN. Levels & Trends in childhood mortality: Report 2020, Estimates developed by the UN Inter-agency Group for Child Mortality Estimation [Internet]. Who/Unicef/World Bank/Un. 2020.
  • 2.UN IGME. Levels & Trends in Child Mortality: Estimates: Report 2018. Who/Unicef/World Bank/Un. 2018;1–48.
  • 3.Gutema GD, Geremew A, Megistu DA, Dammu YM, Bayu K. Trends and Associated Factors of Under-five Mortality Based on 2008–2016 Data in Kersa Health and Demographic Surveillance Site, Eastern Ethiopia. Inq (United States). 2022;59. doi: 10.1177/00469580221090394 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Hill K, Zimmerman L, Jamison DT. Mortality risks in children aged 5–14 years in low-income and middle-income countries: A systematic empirical analysis. Lancet Glob Heal. 2015;3(10):e609–16. doi: 10.1016/S2214-109X(15)00044-3 [DOI] [PubMed] [Google Scholar]
  • 5.Nair H, Byass P. Mortality in older children and adolescents: the forgotten ones. Lancet Child Adolesc Heal. 2018. May;2(5):306–7. doi: 10.1016/S2352-4642(18)30067-1 [DOI] [PubMed] [Google Scholar]
  • 6.Macpherson L, Ogero M, Akech S, Aluvaala J, Gathara D, Irimu G, et al. Risk factors for death among children aged 5–14 years hospitalised with pneumonia: a retrospective cohort study in Kenya. BMJ Glob Heal. 2019;4(5):e001715. doi: 10.1136/bmjgh-2019-001715 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Thakrar AP, Forrest AD, Maltenfort MG, Forrest CB. Child Mortality In The US And 19 OECD Comparator Nations: A 50-Year Time-Trend Analysis. Health Aff [Internet]. 2018. Jan 1;37(1):140–9. Available from: 10.1377/hlthaff.2017.0767 [DOI] [PubMed] [Google Scholar]
  • 8.Kyu HH, Stein CE, Pinto CB, Rakovac I, Weber MW, Purnat TD, et al. Articles Causes of death among children aged 5–14 years in the WHO European Region: a systematic analysis for the Global Burden of Disease Study 2016. Lancet child Adolesc Heal [Internet]. 2016;2(5):321–37. Available from: 10.1016/S2352-4642(18)30095-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Masquelier B, Hug L, Sharrow D, You D, Hogan D, Hill K, et al. Global, regional, and national mortality trends in older children and young adolescents (5–14 years) from 1990 to 2016: an analysis of empirical data. Lancet Glob Heal. 2018;6(10):e1087–99. doi: 10.1016/S2214-109X(18)30353-X [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Liang J, Du Y, Qu X, Ke C, Yi G, Liu M. The Causes of Death and Their Influence in Life Expectancy of Children Aged 5–14 Years in Low- and Middle-Income Countries From 1990 to 2019. 2022;10(May). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Fadel SA, Boschi-pinto C, Yu S, Reynales-shigematsu LM, Menon GR, Newcombe L, et al. Trends in cause-specific mortality among children aged 5–14 years from 2005 to 2016 in India, China, Brazil, and Mexico: an analysis of nationally representative mortality studies. Lancet [Internet]. 2019;393(10176):1119–27. Available from: doi: 10.1016/S0140-6736(19)30220-X [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Ngari MM, Obiero C, Mwangome MK, Nyaguara A, Mturi N, Murunga S, et al. Mortality during and following hospital admission among school-aged children: a cohort study. Wellcome open Res. 2020;5:234. doi: 10.12688/wellcomeopenres.16323.2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Osano BO, Were F, Mathews S. Mortality among 5–17 year old children in Kenya. Pan Afr Med J. 2017;27:1–7. doi: 10.11604/pamj.2017.27.121.10727 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Robison JA, Ahmad ZP, Nosek CA, Durand C, Namathanga A, Milazi R, et al. Decreased pediatric hospital mortality after an intervention to improve emergency care in Lilongwe, Malawi. Pediatrics. 2012. Sep;130(3):e676–82. [DOI] [PubMed] [Google Scholar]
  • 15.Hau DK, Chami N, Duncan A, Smart LR, Hokororo A, Kayange NM, et al. Post-hospital mortality in children aged 2–12 years in Tanzania: A prospective cohort study. PLoS One. 2018;13(8):1–13. doi: 10.1371/journal.pone.0202334 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Veirum JE, Sodeman M, Biai S, Hedegård K, Aaby P. Increased mortality in the year following discharge from a paediatric ward in Bissau, Guinea-Bissau. Acta Paediatr Int J Paediatr. 2007;96(12):1832–8. [DOI] [PubMed] [Google Scholar]
  • 17.Nemetchek B, English L, Kissoon N, Ansermino JM, Moschovis PP, Kabakyenga J, et al. Paediatric postdischarge mortality in developing countries: A systematic review. BMJ Open. 2018;8(12). doi: 10.1136/bmjopen-2018-023445 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Carlo Irwin A. Panelo, Riti Shimkhada, Orville C. Solon, Stella A. Quimbo JFF and JWP. Understanding Predictors of Postdischarge Deaths: A Prospective Evaluation of Children 5 Years and Younger Discharged From Philippine District Hospitals on JSTOR [Internet]. Available from: https://www.jstor.org/stable/26723822 [DOI] [PubMed] [Google Scholar]
  • 19.Calculation sample size. OpenEpi:Sample Size for X-Sectional,Cohort,and Clinical Trials [Internet]. [cited 2022 Dec 11]. Available from: http://www.openepi.com/SampleSize/SSCohort.htm
  • 20.Kliegman RM. Nelson Textbook of Pediatrics;- adolescent physical and social development. 21st editi. Elsevier; 2019. 4308,4317–4320. [Google Scholar]
  • 21.Moïsi JC, Gatakaa H, Berkley JA, Maitland K, Mturi N, Newton CR, et al. Excess child mortality after discharge from hospital in Kilifi, Kenya: a retrospective cohort analysis. Bull World Health Organ. 2011. Oct;89(10):725–32, 732A. doi: 10.2471/BLT.11.089235 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Wiens MO, Pawluk S, Kissoon N, Kumbakumba E, Ansermino JM, Singer J, et al. Pediatric Post-Discharge Mortality in Resource Poor Countries: A Systematic Review. PLoS One. 2013;8(6). doi: 10.1371/journal.pone.0066698 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.WHO. Verbal autopsy standards [Internet]. 2012. p. 109–26. Available from: www.who.int [Google Scholar]

Decision Letter 0

Deogratias Munube

18 Oct 2023

PONE-D-23-16416A STUDY PROTOCOL FOR PREDICTORS OF POST-DISCHARGE MORTALITY AMONG CHILDREN AGED 5-14 YEARS ADMITTED TO TERTIARY HOSPITALS IN TANZANIA: A PROSPECTIVE OBSERVATIONAL COHORT STUDY.PLOS ONE

Dear Dr. MELEKI,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Dec 02 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Deogratias Munube

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript. 

Additional Editor Comments:

Dear Author,

Thank you for the submission. I have provided a few comments to improve your manuscript. Starting with the abstract. this is inconsistent with the whole body of the study protocol. The protocol needs a review of the English grammar. The methods described needs to be improved. For example, the method of recruitment is inconsistent. In one sentence, it is reported that the participants will be conveniently recruited and in another sentence consecutively recruited. The other need to be consistent. The justification for the study does include lack of studies in sub Saharan Africa. However, there are several studies referenced in East Africa. The authors need to improve the justification for the study. The list of abbreviations needs to be listed in alphabetical order. The author indicates that he did not receive any funds but later states that his hospital provided funds. This needs to be corrected. The author acknowledges the contribution of the local university for providing HINARI, this needs to be clarified. Did the university buy the HINARI account for the author. The author does indicate that this is his masters thesis project and does not describe if this is a requirement for his university to publish the protocol? The outcomes stated in the protocol is not consistent. The author needs to correct the impression that the initial primary outcome varies in the manuscript. The study sites need to be clearly described such that a reader understands why the three hospital sites need to be used. The process of recruitment and follow up needs to be clearly described. The telephone call script needs to be added to the protocol. The verbal autopsy guides needs to be included in the manuscript. For the confirmation of the possible cause of death at home or in the community, an document needs to be added to show the reader what process will be used to get that information from the parent or care giver. In the submission, it is indicated that there are no data tables submitted but in the manuscript there are two tables referenced. Are these dummy tables?

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.

Reviewer #1: Yes

**********

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?

The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.

Reviewer #1: Partly

**********

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?

Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.

Reviewer #1: No

**********

4. Have the authors described where all data underlying the findings will be made available when the study is complete?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.

(Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The study protocol provides a clear description of the research design and objectives. The authors aim to investigate post-discharge mortality among children aged 5-14 years in Tanzania and identify predictors of mortality at 3 months after discharge. The protocol outlines the study setting, sample size calculation, inclusion and exclusion criteria, variables to be collected, data collection methods, data management procedures, and data analysis plan.

The strengths of the study protocol include its prospective observational cohort design, which allows for the examination of multiple predictors on post-discharge mortality. The inclusion of three different tertiary hospitals increases the generalizability of the findings. The enrollment of consecutive participants and the involvement of research assistants who are not directly involved in patient care help minimize bias. The use of structured questionnaires and a modified verbal autopsy tool enhances data collection.

However, there are a few areas where the protocol could be improved.

1. The protocol lacks a clear research question or hypothesis, which would provide a focused direction for the study. Though some clues about what the study seeks to achieve can be found in the concluding part of the background, no hypothesis has been proposed to direct the focus of the study.

2. While the candidate variables for predicting post-discharge mortality are listed, there is no explicit explanation of their rationale or theoretical basis. Providing this information would strengthen the study's justification for selecting these variables.

3. The authors have not provided details about the data collection approach. The protocol could benefit from a more detailed description of the data collection process, including how the structured questionnaires will be administered and the training provided to the research assistants. It would also be helpful to clarify how missing data will be handled and accounted for in the analysis.

4. In the data analysis section, the protocol states that univariable and multivariable Cox regression analyses will be used to determine factors associated with mortality. However, there is no mention of potential confounding variables or how they will be addressed in the analysis. It would be important to consider potential confounders and adjust for them in the multivariable analysis to obtain more accurate estimates of the predictors' effects. A protocol must necessarily show more details about the study, accounting for possible limitations are hoe the

5. The discussion section provides a brief overview of the study's aims and potential implications, This section could be expanded to include a more thorough interpretation of the results to expect. The limitations section highlights some potential limitations, such as missing data and the challenges of conducting verbal autopsies over the phone. However, it would be beneficial to discuss these limitations in more detail and address strategies to mitigate them.

Overall, the study protocol in its current form does not meet the requirements of a study protocol. It is not detailed and elaborate enough to allow for replication of the study. By addressing the aforementioned areas of improvement, the protocol can be further strengthened to ensure the study's rigor and validity.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 May 22;19(5):e0287243. doi: 10.1371/journal.pone.0287243.r002

Author response to Decision Letter 0


7 Nov 2023

1. The protocol lacks research question/hypothesis-

Response: The research questions have been added to the protocol. The research question has been made clear in the protocol. The questions have been stated on page 4.

2. Candidate variables lack theoretical basis

Response: A figure of legend has been added to the protocol page 8

3. The author has not provided details about data collection, how the questionnaire will be administered and how research assistants will be trained?

response: This has been explained page 9

4. In data analysis section it has not been stated how missing data will be addressed or confounders will be handled

Response: This has been addressed on page 11

5. The discussion section should be expanded to explain the expected results, limitations and how to mitigate them.

Response: This has been explained on page 13

6.Clarification about Hinari

Response: Page 15

7.Why was it necessary for the research to be conducted in three institutions?

Response: It is addressed on page 5

8. There is inconsistencies in the methodology, in some sentences it is written participants will be recruited conviniently and in the other sentence written will be recruited consecutively

Response: It has been responded on page 6

9. Grammar is not correct

Response: Grammar has been corrected using Grammarly app

10. Abbreviations not in alphabetical order

Response: corrections made page 14

11. Sample size has not been well explained.

Response: Addressed well on page 6

12. There was controversy on the statement about funding.

This has been addressed on page 14 and also on the cover letter corrections have been made.

Attachment

Submitted filename: Response to reviewers.docx

pone.0287243.s001.docx (12.6KB, docx)

Decision Letter 1

Deogratias Munube

7 May 2024

A STUDY PROTOCOL FOR PREDICTORS OF POST-DISCHARGE MORTALITY AMONG CHILDREN AGED 5-14 YEARS ADMITTED TO TERTIARY HOSPITALS IN TANZANIA: A PROSPECTIVE OBSERVATIONAL COHORT STUDY.

PONE-D-23-16416R1

Dear Dr. ELTON Roman Meleki

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Deogratias Munube

Academic Editor

PLOS ONE

Acceptance letter

Deogratias Munube

10 May 2024

PONE-D-23-16416R1

PLOS ONE

Dear Dr. Meleki,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Deogratias Munube

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Response to reviewers.docx

    pone.0287243.s001.docx (12.6KB, docx)

    Data Availability Statement

    No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES